Worldwide Clinical Trials
高管
查看带有其 80 名主要高管的组织结构图
Worldwide Clinical Trials 搜索最多的简介
- Peter Benton, President and Chief Executive Officer
- Neal Cutler, Chief Executive Officer
- David Bowser, Executive Vice President and Chief Operating Officer
高管在Worldwide Clinical Trials变化
- JP Kotha已作为Vice President, Bioanalytical加入公司 (新闻发布的2023十一月30号).
创建提醒
跟踪 Worldwide Clinical Trials 的高管变动
药店
Worldwide Clinical Trials 拥有 1,861 家竞争者，其中包括 Pfizer (美国(美洲))、Sanofi (法国) 和 Johnson & Johnson (美国(美洲))。
Popular M&A news in 药店
- MedMen has filed for bankruptcy protection (公布2024四月28号).
- AstraZeneca has announced the acquisition of Fusion Pharma (公布2024三月23号).
- AstraZeneca has announced the acquisition of Amolyt Pharma (公布2024三月19号).
药店 行业的其他推荐联系人
消息
Worldwide Clinical Trials 的最新新闻稿
- Podcast with Joy Clark: Creating a Culture of Belonging
- Articles Archive
- Worldwide Clinical Trials Expands Global Footprint of Large Molecule Services with New Lab at Bioanalytical Center of Excellence
- Worldwide Clinical Trials Appoints Barry Lederman as Chief Financial Officer
- Kohlberg signs a definitive agreement to acquire majority stake in Worldwide Clinical Trials
- Worldwide Clinical Trials Partners with Every Cure to Accelerate Discovery of Treatments for Rare Disease Patients
- Worldwide Clinical Trials Appoints Pete Duprat as Sr. Vice President, Commercial, Early Phase
- News from a Worldwide Sponsor: AnaCardio Receives Regulatory Approval to Start a Phase 1b/2a Clinical Study in Heart Failure with AC01 in the EU and UK
- Worldwide Clinical Trials Appoints Barry Lederman as Chief Financial Officer
- Worldwide Clinical Trials Expands Global Footprint of Large Molecule Services with New Lab at Bioanalytical Center of Excellence
- View more press releases Close
通过电子邮件
